The EDC is live today — see what ships now
All studies
NCT07173855From ClinicalTrials.govRecruiting

Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients

Effect of Protocolized Magnesium Replacement in Critically Ill Patients on Mortality and Atrial Fibrillation: the MAGNOLIA Randomized Controlled Trial

  • Critical Illness

At a glance

Phase
Phase 4
Study type
Interventional
Sponsor
Scarborough General Hospital
Enrolment target
3,853
Started
25 November 2025
Main results due
1 March 2027
Study sites
6
Registry updated
24 September 2026

Can you take part?

  • Aged 16 years and over.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Age 16 years or older
* Admission orders written to a medical-surgical intensive care unit at a participating site
* Magnesium replacement protocol ordered

Exclusion Criteria:

* Prior enrollment in or withdrawal from MAGNOLIA trial
* Sustained ventricular tachycardia
* Pre-eclampsia
* Myasthenia gravis

What this study is about

In the sponsor’s own words, from the registry.

In patients with critical illness, such as severe infections, heart attacks, or respiratory failure, most intensive care units (ICUs) measure magnesium levels and give supplemental doses of magnesium when levels are below certain targets. However, the best targets are unknown. The goal of this clinical trial is to study protocols for magnesium supplementation in people with critical illness, comparing a protocol with higher target level to a protocol with a lower target level.

The main question this study aims to answer is whether magnesium supplementation protocols targeting a higher or lower level lead to better 30-day survival and less atrial fibrillation.

Participants will not have to do any specific tasks, undergo any additional tests, or complete any surveys.

Study sites(6)

  • Lakeridge Health Ajax-Pickering

    Ajax, Ontario, Canada

    Recruiting

  • Lakeridge Health Bowmanville

    Bowmanville, Ontario, Canada

    Recruiting

  • Lakeridge Health Oshawa

    Oshawa, Ontario, Canada

    Recruiting

  • Scarborough Centenary Hospital

    Toronto, Ontario, Canada

    Recruiting

  • Scarborough General Hospital

    Toronto, Ontario, Canada

    Recruiting

  • Scarborough Birchmount Hospital

    Toronto, Ontario, Canada

    Recruiting

Showing 6 of 6 sites. 6 of the 6 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07173855. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients | Trialion